SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

29 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 1485.30 millions, about 15.35% up against Rs. 1287.70 millions recorded during the year-ago period.The Net Profit of the company reported a remarkable increase of 211.57% to Rs. 75.40  millions  from Rs. 24.20 millions in previous same quarter.Operating profit for the quarter ended March 2023 rose to 242.70 millions as compared to 97.80 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1485.30 1287.70 15.35 5376.60 5767.10 -6.77 5376.60 5767.10 -6.77
Other Income 32.40 24.70 31.17 101.70 84.30 20.64 101.70 84.30 20.64
PBIDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Depreciation 80.60 73.60 9.51 313.70 325.80 -3.71 313.70 325.80 -3.71
PBT 162.10 24.20 569.83 403.30 446.70 -9.72 403.30 446.70 -9.72
TAX 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
Deferred Tax 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
PAT 75.40 24.20 211.57 289.60 489.90 -40.89 289.60 489.90 -40.89
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 16.34 7.59 115.15 13.34 13.39 -0.44 13.34 13.39 -0.44

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×